《大行報告》大和下調旺旺(00151.HK)目標價至7元 評級「買入」
大和發表報告指,中國旺旺(00151.HK)旗下乳飲料產品受疫情限制影響,毛利率受壓令淨利按年下跌24%,重申集團「買入」評級,目標價由8.6元下調至7元。
由於更高的原材料成本及上半財年較預期緩慢的乳飲飲品銷售,該行下調集團2023財年至2024財年的每股盈測6至14%。
該行引述中國旺旺管理層指,2022財年第三季仍然充滿挑戰,而原材料成本壓力略有緩解,價格上漲自2022年初以來保持中單位數。另外,其越南工廠亦在上半財年投入營運,料將成為未來進一步擴展東南亞市場和發展分銷網絡的基地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.